GI
ABVX icon

GAMMA Investing’s Abivax ABVX Stock Holding History

GAMMA Investing’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$64.7K Buy
653
+66
+11% +$7.96K ﹤0.01% 2195
2026
Q2 		$78.2K Buy
587
+39
+7% +$4.41K ﹤0.01% 1992
2026
Q1 		$61K Sell
548
-8
-1% -$947 ﹤0.01% 2053
2025
Q4 		$75K Sell
556
-82
-13% -$8.95K ﹤0.01% 1784
2025
Q3 		$54.2K Sell
638
-7
-1% -$429 ﹤0.01% 1927
2025
Q2 		$4.93K Sell
645
-2,368
-79% -$15.4K ﹤0.01% 3127
2025
Q1 		$18.8K Sell
3,013
-963
-24% -$6.52K ﹤0.01% 2417
2024
Q4 		$29.1K Buy
+3,976
New +$36.6K ﹤0.01% 2061

Other funds holding ABVX

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

GAMMA Investing's ABVX Position: Q3 2026 in Review

GAMMA Investing increased its Abivax (ABVX) stake by 11% in Q3 2026, buying an estimated $7.96K and bringing the position to 653 shares worth $64.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2195.

GAMMA Investing first reported a position in ABVX in Q4 2024 and has held it in 8 quarters since. The position peaked at $78.2K in Q2 2026. 9 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • GAMMA Investing held 653 shares of Abivax worth $64.7K as of Q3 2026.
  • GAMMA Investing bought 66 Abivax shares in Q3 2026, an estimated $7.96K.
  • Abivax made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2195 holding.
  • GAMMA Investing first reported a position in Abivax in Q4 2024 and has held it in 8 quarters since.
  • GAMMA Investing's Abivax position peaked at $78.2K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.